🇺🇸 FDA
Patent

US 12234474

Method to prevent the myelin abnormalites associated with arginase deficiency

granted A61KA61K31/7088A61K38/50

Quick answer

US patent 12234474 (Method to prevent the myelin abnormalites associated with arginase deficiency) held by The Regents of the University of California expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7088, A61K38/50, A61K47/26, A61K48/00